Home175250 • KOSDAQ
add
Icure Pharmaceutical Inc
Previous close
₩2,170.00
Year range
₩1,399.00 - ₩2,950.00
Market cap
81.50B KRW
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 25.26B | 50.01% |
Operating expense | 6.21B | 4.66% |
Net income | -9.53B | -1,861.02% |
Net profit margin | -37.75 | -1,206.23% |
Earnings per share | — | — |
EBITDA | -3.31B | -84.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.06B | 11.54% |
Total assets | 128.95B | -17.95% |
Total liabilities | 77.67B | -24.82% |
Total equity | 51.27B | — |
Shares outstanding | 37.37M | — |
Price to book | 1.63 | — |
Return on assets | -9.93% | — |
Return on capital | -12.81% | — |
Cash Flow
Net change in cash
| (KRW) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -9.53B | -1,861.02% |
Cash from operations | 3.78B | 209.13% |
Cash from investing | 12.09B | 71.85% |
Cash from financing | -10.57B | -410.63% |
Net change in cash | 5.30B | 252.71% |
Free cash flow | 7.36B | 310.12% |
About
Founded
2000
Website
Employees
210
